IAA
ALXN

Independent Advisor Alliance’s Alexion Pharmaceuticals ALXN Stock Holding History

Independent Advisor Alliance’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,275
Closed -$418K – 686
2021
Q2 		$418K Sell
2,275
-69
-3% -$11.8K 0.02% 429
2021
Q1 		$358K Sell
2,344
-57
-2% -$8.82K 0.02% 448
2020
Q4 		$375K Buy
+2,401
New +$309K 0.03% 404
2020
Q2 		– Sell
-2,470
Closed -$222K – 551
2020
Q1 		$222K Sell
2,470
-121
-5% -$11.9K 0.03% 342
2019
Q4 		$280K Buy
+2,591
New +$277K 0.01% 699

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Independent Advisor Alliance's ALXN Position: Q3 2021 in Review

Independent Advisor Alliance sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 2,275 shares — an estimated $418K sold.

Independent Advisor Alliance first reported a position in ALXN in Q4 2019 and held it in 5 quarters. The position peaked at $418K in Q2 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Independent Advisor Alliance reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Independent Advisor Alliance sold 2,275 Alexion Pharmaceuticals shares in Q3 2021, an estimated $418K.
  • Independent Advisor Alliance first reported a position in Alexion Pharmaceuticals in Q4 2019 and held it in 5 quarters.
  • Independent Advisor Alliance's Alexion Pharmaceuticals position peaked at $418K in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Independent Advisor Alliance's 13F filing for Q3 2021, filed 1 Nov 2021.